Trial Profile
Clinical Trials Insight: 700050903
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs Dienogest (Primary) ; Leuprorelin
- Indications Endometriosis; Pelvic pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer HealthCare Pharmaceuticals
- 01 Jun 2012 Results published in the International Journal of Gynaecology and Obstetrics.
- 01 Mar 2010 Results published in Human Reproduction.
- 11 Nov 2009 New trial record